Search results
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
CNN via Yahoo News Singapore· 4 days agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.
I’m a Financial Planning Expert: You’re Right About Your Retirement Savings If …
GOBankingRates via Yahoo Singapore Finance· 3 days agoFinding the magic number for your retirement savings is no easy feat. According to a recent survey...
FDA approves a second Alzheimer's drug that can modestly slow disease
Associated Press Finance via Yahoo Singapore Finance· 4 days agoU.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing...